Ignite Creation Date:
2025-12-24 @ 9:15 PM
Ignite Modification Date:
2025-12-30 @ 11:24 PM
Study NCT ID:
NCT04329104
Status:
COMPLETED
Last Update Posted:
2025-04-09
First Post:
2020-03-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of CIS43LS Anti-malaria mAb in Mali
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-05
Completion Date Type:
ACTUAL
First Submit Date:
2020-03-30
First Submit QC Date:
None
Study First Post Date:
2020-04-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-04-03
Results First Submit QC Date:
None
Results First Post Date:
2024-05-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-20
Last Update Post Date:
2025-04-09
Last Update Post Date Type:
ACTUAL